[PDF][PDF] New frontiers in the treatment of type 1 diabetes

JT Warshauer, JA Bluestone, MS Anderson - Cell metabolism, 2020 - cell.com
Type 1 diabetes is an autoimmune disease caused by the immune-mediated destruction of
pancreatic β cells that results in lifelong absolute insulin deficiency. For nearly a century …

The heterogeneous pathogenesis of type 1 diabetes mellitus

J Ilonen, J Lempainen, R Veijola - Nature Reviews Endocrinology, 2019 - nature.com
Type 1 diabetes mellitus (T1DM) results from the destruction of pancreatic β-cells that is
mediated by the immune system. Multiple genetic and environmental factors found in …

T cells in patients with narcolepsy target self-antigens of hypocretin neurons

D Latorre, U Kallweit, E Armentani, M Foglierini, F Mele… - Nature, 2018 - nature.com
Narcolepsy is a chronic sleep disorder caused by the loss of neurons that produce
hypocretin. The close association with HLA-DQB1* 06: 02, evidence for immune …

Type 1 diabetes

T Quattrin, LD Mastrandrea, LSK Walker - The Lancet, 2023 - thelancet.com
Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β
cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite enhanced …

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

T Delong, TA Wiles, RL Baker, B Bradley, G Barbour… - Science, 2016 - science.org
T cell–mediated destruction of insulin-producing β cells in the pancreas causes type 1
diabetes (T1D). CD4 T cell responses play a central role in β cell destruction, but the identity …

[HTML][HTML] T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes

AL Burrack, T Martinov, BT Fife - Frontiers in endocrinology, 2017 - frontiersin.org
Type 1 diabetes (T1D) results from destruction of pancreatic beta cells by T cells of the
immune system. Despite improvements in insulin analogs and continuous blood glucose …

Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes

JAB Babon, ME DeNicola, DM Blodgett, I Crèvecoeur… - Nature medicine, 2016 - nature.com
A major therapeutic goal for type 1 diabetes (T1D) is to induce autoantigen-specific
tolerance of T cells. This could suppress autoimmunity in those at risk for the development of …

Human islet T cells are highly reactive to preproinsulin in type 1 diabetes

AM Anderson, LG Landry… - Proceedings of the …, 2021 - National Acad Sciences
Cytotoxic CD8 T lymphocytes play a central role in the tissue destruction of many
autoimmune disorders. In type 1 diabetes (T1D), insulin and its precursor preproinsulin are …

Solid organ bioprinting: strategies to achieve organ function

AM Jorgensen, JJ Yoo, A Atala - Chemical reviews, 2020 - ACS Publications
The field of tissue engineering has advanced over the past decade, but the largest impact on
human health should be achieved with the transition of engineered solid organs to the clinic …

The challenge of modulating β-cell autoimmunity in type 1 diabetes

MA Atkinson, BO Roep, A Posgai… - The Lancet Diabetes & …, 2019 - thelancet.com
With the conceptual advance about four decades ago that type 1 diabetes represents an
autoimmune disease, hope arose that immune-based therapies would soon emerge to …